Stephen R.D. Johnston
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 27
- HER2/EGFR in Cancer Research 17
- Cancer Treatment and Pharmacology 11
-
- Breast Cancer Treatment Studies 14
- Co-authors
- Mitch Dowsett (9 shared papers)Anthony Howell (1 shared paper)Sacha Jon Howell (1 shared paper)Roger A’Hern (3 shared papers)L Pyle (2 shared papers)Matthew M. Vaughan (2 shared papers)Tim G Eisen (2 shared papers)Francisco J. Sapunar (1 shared paper)
- Journals
- British Journal of Cancer (3 papers)Annals of Oncology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Breast Cancer Research (2 papers)Clinical Oncology (2 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Stephen R.D. Johnston
44 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 91
- Oncology 940
- Cancer Research 477
- Genetics 726
- Molecular Biology 986
- Toxicology 38
Countries citing papers authored by Stephen R.D. Johnston
This map shows the geographic impact of Stephen R.D. Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen R.D. Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen R.D. Johnston more than expected).
Fields of papers citing papers by Stephen R.D. Johnston
This network shows the impact of papers produced by Stephen R.D. Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen R.D. Johnston. The network helps show where Stephen R.D. Johnston may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen R.D. Johnston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 299 | |
| 2 | 2003 | 262 | |
| 3 | 2016 | 240 | |
| 4 | 2003 | 168 | |
| 5 | Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance. | 1999 | 132 |
| 6 | 2003 | 120 | |
| 7 | 2001 | 117 | |
| 8 | 1997 | 112 | |
| 9 | 2005 | 70 | |
| 10 | 2005 | 68 | |
| 11 | 2005 | 54 | |
| 12 | Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis. | 1999 | 53 |
| 13 | 2007 | 45 | |
| 14 | 2010 | 42 | |
| 15 | Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies. | 2001 | 39 |
| 16 | Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer. | 2006 | 38 |
| 17 | 2006 | 34 | |
| 18 | 2011 | 34 | |
| 19 | 2013 | 34 | |
| 20 | 2002 | 32 |
About Stephen R.D. Johnston
Stephen R.D. Johnston is a scholar working on Oncology, Cancer Research, Genetics, Molecular Biology and Toxicology, having authored 49 papers that have together received 2.3k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (21 papers), HER2/EGFR in Cancer Research (17 papers), Breast Cancer Treatment Studies (14 papers), Cancer Treatment and Pharmacology (11 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Retinoids in leukemia and cellular processes (3 papers), Genomics and Chromatin Dynamics (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Oncology (940 citations), Cancer Research (477 citations), Genetics (726 citations), Molecular Biology (986 citations) and Toxicology (38 citations). Stephen R.D. Johnston has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Mitch Dowsett, Anthony Howell, Sacha Jon Howell, Roger A’Hern, L Pyle, Matthew M. Vaughan, Tim G Eisen, Francisco J. Sapunar, Ian Mak and CHRIS H. BOSHOFF. Their work appears in journals such as British Journal of Cancer, Annals of Oncology, Cancer Chemotherapy and Pharmacology, Breast Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.